---
title: "Top 10 港股跌幅（7月25日）"
description: "广联科技控股 (02531) 跌 11.39%，成交额 1603.3 万港元，年内累计跌 52.5%。 美图公司 (01357) 跌 10.64%，成交额 23.4 亿港元，年内累计涨 256%。 云顶新耀 (01952) 跌 9.74%，成交额 31.6 亿港元，年内累计涨 44.6%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/250235241.md"
published_at: "2025-07-26T08:30:51.000Z"
---

# Top 10 港股跌幅（7月25日）

> 广联科技控股 (02531) 跌 11.39%，成交额 1603.3 万港元，年内累计跌 52.5%。 美图公司 (01357) 跌 10.64%，成交额 23.4 亿港元，年内累计涨 256%。 云顶新耀 (01952) 跌 9.74%，成交额 31.6 亿港元，年内累计涨 44.6%。

恒生指数跌 1.09%，年内累计涨 26.6%；恒生科技指数跌 1.13%，年内累计涨 27.1%。

广联科技控股 (02531) 跌 11.39%，成交额 1603.3 万港元，年内累计跌 52.5%。

美图公司 (01357) 跌 10.64%，成交额 23.4 亿港元，年内累计涨 256%。

云顶新耀 (01952) 跌 9.74%，成交额 31.6 亿港元，年内累计涨 44.6%。

### Related Stocks

- [02531.HK - 广联科技控股](https://longbridge.com/zh-CN/quote/02531.HK.md)
- [01357.HK - 美图公司](https://longbridge.com/zh-CN/quote/01357.HK.md)
- [01952.HK - 云顶新耀](https://longbridge.com/zh-CN/quote/01952.HK.md)
- [00933.HK - 非凡领越](https://longbridge.com/zh-CN/quote/00933.HK.md)
- [06655.HK - 华新建材](https://longbridge.com/zh-CN/quote/06655.HK.md)
- [01072.HK - 东方电气](https://longbridge.com/zh-CN/quote/01072.HK.md)
- [01276.HK - 恒瑞医药](https://longbridge.com/zh-CN/quote/01276.HK.md)
- [01286.HK - 鹰普精密](https://longbridge.com/zh-CN/quote/01286.HK.md)
- [01530.HK - 三生制药](https://longbridge.com/zh-CN/quote/01530.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Angry passengers left high and dry after Star Cruises cancels Hong Kong sailing | Star Cruises cancelled a scheduled sailing from Hong Kong due to an unforeseen technical issue, leaving passengers frust | [Link](https://longbridge.com/zh-CN/news/275957717.md) |
| Meitu Sees 2025 Net Profit Between 60-66% Y/Y By IFRS | Meitu Inc :SEES 2025 NET PROFIT BETWEEN 60-66% Y/Y BY IFRS | [Link](https://longbridge.com/zh-CN/news/275224699.md) |
| Everest Medicines erhält Zulassung für VELSIPITY in China | Everest Medicines Ltd. has received approval from the National Medical Products Administration (NMPA) in China for VELSI | [Link](https://longbridge.com/zh-CN/news/275069370.md) |
| Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | [Link](https://longbridge.com/zh-CN/news/273791098.md) |
| Is Now The Time To Look At Buying Meitu, Inc. (HKG:1357)? | Meitu, Inc. (HKG:1357) has seen a share price increase of over 10% recently, but it remains below its yearly peak. Analy | [Link](https://longbridge.com/zh-CN/news/274087132.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。